Lexington, KY 的 心血管疾病 臨床試驗
8 項針對 心血管疾病 的研究正在 Lexington（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- The Research Group of Lexington, Lexington
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
招募中3 期
- Clinical Trial Site, Lexington
- Clinical Trial Site, Versailles · 距離 14 英里
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
招募中
- University of Kentucky, Lexington
Cardiovascular Biorepository
招募中觀察性研究
- University of Kentucky, Department of Internal Medicine, Division of Cardiovascular Medicine, Lexington
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
招募中3 期
- Research Site, Lexington
- Research Site, Lexington
- Research Site, Versailles · 距離 14 英里
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
招募中3 期
- Baptist Health Lexington, Lexington
- The Research Group of Lexington LLC, Lexington
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
招募中
- University of Kentucky, Lexington
Biopsy Collection and Repository Database
招募中觀察性研究
- University of Kentucky, Lexington
其他城市的 心血管疾病 試驗
- Boston, MA37 項研究
- New York City, NY33 項研究
- Washington, DC28 項研究
- Houston, TX24 項研究
- Dallas, TX23 項研究
- Atlanta, GA22 項研究
- Cleveland, OH22 項研究
- Chicago, IL21 項研究
- Philadelphia, PA21 項研究
- Pittsburgh, PA20 項研究
- St. Louis, MO20 項研究
- Nashville, TN18 項研究
Lexington 的其他研究
- 非小細胞肺癌23 項研究
- 肺癌18 項研究
- 卵巢癌16 項研究
- 前列腺癌14 項研究
- 癌症（所有類型）14 項研究
- 乳癌14 項研究
- 轉移性癌症11 項研究
- 大腸直腸癌11 項研究
- 心臟衰竭11 項研究
- 黑色素瘤10 項研究
- 急性髓系白血病10 項研究
- 肥胖症10 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。